The Food and Drug Administration (FDA) has approved Wandercraft's Atalante exoskeleton for stroke rehabilitation, as reported by Engadget. David Zabala, an 8-year-old boy with cerebral palsy, is ...

The Food and Drug Administration has cleared a new exoskeleton for use in stroke rehabilitation, its manufacturer announced this week. Known as Atalante, the self-balancing, battery-powered ...

Stroke patients in the US could soon take advantage of cutting-edge robotics during the recovery process. The Food and Drug Administration has cleared Wandercraft's Atalante exoskeleton for use in ...

French company Wandercraft is taking a groundbreaking step forward to give individuals with disabilities a chance to walk again. The company is using cutting-edge technology to develop the world's ...

Wandercraft, a maker of self-balancing robotic mobility systems, has secured $75 million in funding to accelerate AI-powered robotics. This influx of capital arrives during a time of rapid growth, ...

This marks Wandercraft’s second FDA clearance for Atalante X, the world’s first self-balancing exoskeleton, following clearance for stroke rehabilitation in December 2022 FDA clearance paves the way ...

The world’s first self-stabilising walking exoskeleton, Atlante X, has entered a rehabilitation trial in Germany. The exoskeleton will be provided to patients with hemiparesis, an after-effect of ...

NEW YORK, US and PARIS, France, 13 July 2023-- Wandercraft, the developer of the world's first self-stabilized walking exoskeleton, designed to enable people with walking impairments to stand up and ...